Industry Statistics and Trends
Market size and recent performance (2014-2029)
Industry revenue has declined at a CAGR of 3.6 % over the past five years, to reach an estimated $7.5bn in 2024.
Trends and Insights
Biosimilar competition poses a challenge to branded drug sales
- Brand name pharmaceuticals continue to account for the largest share of prescription drug spending in the Canadian market. Data from IQVIA Pharmafocus shows brand-name products accounted for 80.5% of Canadian sales by value and 25.7% of total prescriptions by quantity. Still, this disparity underscores the high cost of branded medications compared to generics.
- Additional trends and insights available with purchase
Source: Alfabank-Adres
Industry outlook (2024-2029)
Market size is projected to grow over the next five years.
Trends and Insights
Calming inflation will boost exports
- The Canadian dollar is expected to deflate in the coming years as the economy finishes its normalization process in the wake of the COVID-19 pandemic.
Biggest companies in the Brand-Name Pharmaceutical Manufacturing in Canada
| Company | Market Share (%)
2024 | Revenue ($m)
2024 | Profit ($m)
2024 | Profit Margin (%)
2024 |
|---|---|---|---|---|
Sanofi | 1,487.5 | 243.0 | 16.3 | |
Gilead | 1,034.7 | 197.4 | 19.1 | |
Pfizer | 829.9 | 53.9 | 6.5 |
To view the market share and analysis for all 5 top companies in this industry, view purchase options.
Products & Services Segmentation
Source: Alfabank-Adres
Industry revenue is measured across several distinct product and services lines, including Nervous system and cardiovascular drugs, Antineoplastic and immunomodulating agents and Alimentary tract and metabolism drugs. Nervous system and cardiovascular drugs is the largest segment of the Brand-Name Pharmaceutical Manufacturing in Canada.
Trends and Insights
Antineoplastic and immunomodulating agents are crucial to revenue
- More than two-fifths of revenue for brand-name pharmaceutical manufacturers comes from antineoplastic and immunomodulating agents. These are designed to control or kill tumors.
- More insights available in the full report
Table of Contents
About this industry
Industry definition
Brand name pharmaceutical manufacturers develop, produce and market drugs under a trademarked brand name. These companies typically invest significant time and money in researching, developing and conducting clinical trials for new medications.
What's included in this industry?
Pharmaceutical research and developmentManufacturing active ingredients used in pharmaceuticalsManufacturing chemical pharmaceutical preparationsManufacturing biological pharmaceutical productsCompanies
SanofiGileadPfizerPurchase this report to view all 5 major companies in this industry.
Related Terms
BIOLOGICBIOSIMILARBLOCKBUSTER DRUGPATENT CLIFFIndustry Code
NAICS 325410 - Brand-Name Pharmaceutical Manufacturing in Canada
Performance
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
Analyst insights
External competition from generic pharmaceuticals has been rampant in recent years. This has caused revenue decline as drug plans favour less expensive generic products.
In this chapter (4)
- Current Performance
- Outlook
- Volatility
- Life Cycle
Key metrics
- Annual Revenue, Recent Growth, Forecast, Revenue Volatility
- Number of Employees, Recent Growth, Forecast, Employees per Business, Revenue per Employee
- Number of Businesses, Recent Growth, Forecast, Employees per Business, Revenue per Business
- Total Profit, Profit Margin, Profit per Business
Charts
- Revenue, including historical (2014-2023) and forecast (2024-2029)
- Employees, including historical (2014-2023) and forecast (2024-2029)
- Businesses, including historical (2014-2023) and forecast (2024-2029)
- Profit, including historical (2014-2024)
- Industry Volatility vs. Revenue Growth
- Industry Life Cycle
Detailed analysis
- Trends in supply, demand and current events that are driving current industry performance
- Expected trends, economic factors and ongoing events that drive the industry's outlook
- Key success factors for businesses to overcome volatility
- How contribution to GDP, industry saturation, innovation, consolidation, and technology and systems influence the industry's life cycle phase.
Products and Markets
Learn about an industry's products and services, markets and trends in international trade.
Analyst insight
Nearly half of brand name manufacturers’ revenue comes from oncology treatments. The growing incidence of cancer in Canada and globally drives sales, but recent, transformati...
In this chapter
- Products & Services
- Major Markets
- International Trade
Key metrics
- Largest market segment and value in 2024
- Product innovation level
- Total imports, level and trend
- Total exports, level and trend
- Trade Balance
Charts
- Products & services segmentation in 2024
- Major market segmentation in 2024
- International trade, including imports by country and exports by country
Detailed analysis
- Trends impacting the recent performance of the industry's various segments
- Innovations in the industry's product or service offering, specialization or delivery method
- Key factors that successful businesses consider in their offerings
- Buying segments and key trends influencing demand for industry products and services
- Recent trends in import and export volumes, country of origin or destination, and expected future trends
Geographic Breakdown
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
Analyst insights
Ontario is Canada’s pharmaceutical center. The province hosts a high concentration of pharmaceutical companies, research facilities and academic institutions focused on innov...
In this chapter (1)
- Business Locations
Charts
- Share of revenue, establishment, wages and employment in each province
- Share of population compared to establishments in each region in 2024
Tables
- Number and share of establishments in each province in 2024
- Number and share of revenue each province accounts for in 2024
- Number and share of wages each province accounts for in 2024
- Number and share of employees in each province in 2024
Detailed analysis
- Geographic spread of the industry across North America, and trends associated with changes in the business landscape
- Key success factors for businesses to use location to their advantage
Competitive Forces
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
Analyst insights
Biosimilars are one of the largest threats to brand name pharmaceutical producers. Patents protect brand name manufacturers for a set time, but the entry of biosimilars when ...
In this chapter (4)
- Concentration
- Barriers to Entry
- Substitutes
- Buyer & Supplier Analysis
Key metrics
- Industry concentration level
- Industry competition level and trend
- Barriers to entry level and trend
- Substitutes level and trend
- Buyer power level and trend
- Supplier power level and trend
Charts
- Market share concentration among the top 4 suppliers from 2019-2024
- Supply chain including upstream supplying industries and downstream buying industries, flow chart
Detailed analysis
- Factors impacting the industry’s level of concentration, such as business distribution, new entrants, or merger and acquisition activity.
- Key success factors for businesses to manage the competitive environment of the industry.
- Challenges that potential industry entrants face such as legal, start-up costs, differentiation, labor/capital intensity and capital expenses.
- Key success factors for potential entrants to overcome barriers to entry.
- Competitive threats from potential substitutes for the industry’s own products and services.
- Key success factors for how successful businesses can compete with substitutes.
- Advantages that buyers have to keep favorable purchasing conditions.
- Advantages that suppliers have to maintain favorable selling conditions.
- Key success factors for how businesses can navigate buyer and supplier power.
Companies
Learn about the performance of the top companies in the industry.
Analyst insights
Leading pharmaceutical producers allocate billions of dollars annually to research and development. Massive drug sales and profit enable them to invest in drug development at...
In this chapter
- Market Share Concentration
- Companies
- Company Spotlights
Charts
- Industry market share by company in 2020 through 2024
- Major companies in the industry, including market share, revenue, profit and profit margin in 2024
- Overview of Sanofi's performance by revenue, market share and profit margin from 2018 through 2024
- Overview of Gilead's performance by revenue, market share and profit margin from 2018 through 2024
- Overview of Pfizer's performance by revenue, market share and profit margin from 2018 through 2024
- Overview of revenue, market share and profit margin trend for 2 additional companies
Detailed analysis
- Description and key data for Sanofi, and factors influencing its performance in the industry
- Description and key data for Gilead, and factors influencing its performance in the industry
- Description and key data for Pfizer, and factors influencing its performance in the industry
- Description, key data and performance trends for 2 additional companies
External Environment
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.
Analyst insights
Brand name pharmaceutical manufacturers are navigating an evolving regulatory environment. New regulations impact pricing, market access and patents, and a recently launched ...
In this chapter
- External Drivers
- Regulation & Policy
- Assistance
Key metrics
- Regulation & policy level and trend
- Assistance level and trend
Charts
- Regulation & Policy historical data and forecast (2014-2029)
- Assistance historical data and forecast (2014-2029)
Detailed analysis
- Demographic and macroeconomic factors influencing the industry, including Regulation & Policy and Assistance
- Major types of regulations, regulatory bodies, industry standards or specific regulations impacting requirements for industry operators
- Key governmental and non-governmental groups or policies that may provide some relief for industry operators.
Financial Benchmarks
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.
Analyst insights
Research and development is essential to driving innovation. R&D investments can extend into the hundreds of millions, but it is necessary for brand-name pharmaceutical manuf...
In this chapter
- Cost Structure
- Financial Ratios
- Key Ratios
Key metrics
- Profit margin, and how it compares to the sector-wide margin
- Average wages, and how it compares to the sector-wide average wage
- Largest cost component as a percentage of revenue
- Industry average ratios for days' receivables, industry coverage and debt-to-net-worth ratio
Charts
- Average industry operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Average sector operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Investment vs. share of economy
Data tables
- Liquidity Ratios (2017-2022)
- Coverage Ratios (2017-2022)
- Leverage Ratios (2017-2022)
- Operating Ratios (2017-2022)
- Assets (2017-2022)
- Liabilities (2017-2022)
- Cash Flow & Debt Service Ratios (2014-2029)
- Revenue per Employee (2014-2029)
- Revenue per Enterprise (2014-2029)
- Employees per Establishment (2014-2029)
- Employees per Enterprise (2014-2029)
- Average Wage (2014-2029)
- Wages/Revenue (2014-2029)
- Establishments per Enterprise (2014-2029)
- IVA/Revenue (2014-2029)
- Imports/Demand (2014-2029)
- Exports/Revenue (2014-2029)
Detailed analysis
- Trends in the cost component for industry operators and their impact on industry costs and profitability
Key Statistics
Industry Data
Data Tables
Including values and annual change:
- Revenue (2014-2029)
- IVA (2014-2029)
- Establishments (2014-2029)
- Enterprises (2014-2029)
- Employment (2014-2029)
- Exports (2014-2029)
- Imports (2014-2029)
- Wages (2014-2029)
Top Questions Answered
Unlock comprehensive answers and precise data upon purchase. View purchase options.
What is the market size of the Brand-Name Pharmaceutical Manufacturing industry in Canada in 2024?
The market size of the Brand-Name Pharmaceutical Manufacturing industry in Canada is $7.5bn in 2024.
How many businesses are there in the Brand-Name Pharmaceutical Manufacturing in Canada industry in 2024?
There are 366 businesses in the Brand-Name Pharmaceutical Manufacturing industry in Canada, which has declined at a CAGR of 0.2 % between 2019 and 2024.
Has the Brand-Name Pharmaceutical Manufacturing industry in Canada grown or declined over the past 5 years?
The market size of the Brand-Name Pharmaceutical Manufacturing industry in Canada has been declining at a CAGR of 3.6 % between 2019 and 2024.
What is the forecast growth of the Brand-Name Pharmaceutical Manufacturing industry in Canada over the next 5 years?
Over the next five years, the Brand-Name Pharmaceutical Manufacturing industry in Canada is expected to grow.
What are the biggest companies in the Brand-Name Pharmaceutical Manufacturing market in Canada?
The biggest companies operating in the Brand-Name Pharmaceutical Manufacturing market in Canada are Sanofi, Gilead and Pfizer
What does the Brand-Name Pharmaceutical Manufacturing in Canada include?
Pharmaceutical research and development and Manufacturing active ingredients used in pharmaceuticals are part of the Brand-Name Pharmaceutical Manufacturing industry.
Which companies have the highest market share in the Brand-Name Pharmaceutical Manufacturing in Canada?
The company holding the most market share in Canada is Sanofi.
How competitive is the Brand-Name Pharmaceutical Manufacturing industry in Canada?
The level of competition is very high and increasing in the Brand-Name Pharmaceutical Manufacturing industry in Canada.
Related Industries
Widen your competitive advantage with related industries
Competitors
- Generic Pharmaceutical Manufacturing in Canada
Complementors
- Pharmacies & Drug Stores in Canada
- Scientific Research & Development in Canada
International industries
- Global Pharmaceuticals & Medicine Manufacturing
- Brand Name Pharmaceutical Manufacturing in the US
- Pharmaceutical Product Manufacturing in Australia
- Pharmaceutical Preparations Manufacturing in the UK
- Pharmaceutical Preparations Manufacturing in Ireland
Methodology
How are Alfabank-Adres reports created?
Alfabank-Adres has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for Alfabank-Adres readers. Finally, each report is reviewed by one of Alfabank-Adres’s editors, who provide quality assurance to ensure accuracy and readability.
Alfabank-Adres relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
What data sources do Alfabank-Adres analysts use?
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources in Canada include:
- Statistics Canada
- Industry Canada
- Canadian Business Patterns
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
- Industry and trade associations
- Industry federations or regulators
- Major industry players annual or quarterly filings
Finally, Alfabank-Adres’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
How does Alfabank-Adres forecast its data?
Alfabank-Adres’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
Alfabank-Adres prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the Help Center.
